| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6109965 | Journal of Hepatology | 2009 | 9 Pages | 
Abstract
												Normoglycemia alone cannot prevent hepatic steatosis and glycogen accumulation or the development of HCAs in GSD-Ib, providing one explanation why GSD-Ib patients maintaining normoglycemia under intense dietary therapy continue at risk for this long-term complication.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Gastroenterology
												
											Authors
												Wai Han Yiu, Chi-Jiunn Pan, Paul A. Mead, Matthew F. Starost, Brian C. Mansfield, Janice Y. Chou, 
											